Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Income Before Tax
Profit after all operating and non-operating items but before income tax.
Translational Development Acquisition Corp.NASDAQ: TDAC
Income Before Tax · Q1 FY2026 · quarter ended Mar 2026
Income before tax dips below year-ago levels
Q1 FY2026 income before tax of $1.33M fell 10.1% year over year, behind the +339.7% change in trailing-twelve-month income before tax. Sequentially, it fell 16.5% from the prior quarter.
Context
- Income before tax increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -10.1% toward the trailing-twelve-month pace of +339.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
USD · from the income statement
- Latest · FY2025
- 6.36M USD
- Year-over-year change
- +9059.7%
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.36M | +9059.7% |
| FY2024 | 2024-12-31 | (71.01K) | +85.4% |
| FY2023 | 2023-12-31 | (485.55K) | -587.1% |
| FY2022 | 2022-12-31 | (70.66K) | — |
Income Before Tax vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's LTM Mar 2026 income before tax of $6.21M is the 4th highest of the 7 companies compared; the peer median is $5.53M.
- Its year-over-year change of +339.7% is the 2nd highest of 6, against a peer median of +131.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2022 | $14.78M | +93748.2% | — | — | |
| LTM Mar 2026 | $8.11M | — | +223.3% | — | |
NTWONewbury Street II Acquisition Corp | LTM Mar 2026 | $6.32M | +131.8% | — | — |
| LTM Mar 2026 | $6.21M | +339.7% | — | — | |
MACIMelar Acquisition Corp. I | LTM Mar 2026 | $4.74M | -18.4% | — | — |
| LTM Mar 2026 | $4.6M | +136.8% | -5.7% | — | |
| LTM Mar 2026 | -$11.81M | -1322.5% | — | — | |
| Peer median (excluding TDAC) | $5.53M | +131.8% | +108.8% | — | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 1.07M | 0 |
| Cost of Revenue | 0 | 0 | 320.87K | 0 |
| Gross Profit | 0 | 0 | 744.92K | 0 |
| Gross Margin | — | — | 69.9% | — |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 70.66K | 485.55K | 196.36K | 944.54K |
| Operating Expenses | 70.66K | 485.55K | 196.36K | 944.54K |
| Depreciation & Amortization | 70.66K | 0 | 0 | 0 |
| EBITDA | 0 | (485.55K) | (71.01K) | (944.54K) |
| EBITDA Margin | — | — | -6.7% | — |
| Operating Income | (70.66K) | (485.55K) | (196.36K) | (944.54K) |
| Operating Margin | — | — | -18.4% | — |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 508.56K | 0 |
| Other Income / Expenses | 0 | 0 | 125.35K | 7.31M |
| Income Before Tax | (70.66K) | (485.55K) | (71.01K) | 6.36M |
| Pre-Tax Margin | — | — | -6.7% | — |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | (70.66K) | (485.55K) | (71.01K) | 6.36M |
| Net Margin | — | — | -6.7% | — |
| EPS (Basic) | (0.02) | (0.12) | (0.02) | 0.37 |
| EPS (Diluted) | (0.02) | (0.12) | (0.02) | 0.37 |
| Weighted Avg Shares | 4.05M | 4.05M | 4.05M | 17.25M |
| Weighted Avg Shares (Diluted) | 4.05M | 4.05M | 4.05M | 17.25M |
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.